SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

CSTONE Announces CS2009 Clinical Validation Milestone at ESMO 2026

CSTONE says data from more than 300 patients support CS2009's mechanism, safety and broad antitumor activity.

Related stories